Truncal Tourniquets for the Department of Defense Research On Combat Casualty Care

The Combat Casualty Care Research Program of the Medical Research and Materiel Command (USAMRMC) provides integrated capabilities for far-forward medical care to reduce mortality and morbidity associated with major battlefield wounds and injuries. The USAMRMC is seeking information regarding novel truncal tourniquets, both FDA approved and prototype devices, for hemorrhage control of intracavitary injuries on the battlefield. Interested firms should submit a 1-3 page whitepaper (with additional sheets for diagrams as necessary) describing such devices and the concept of use. Information will be reviewed pursuant to consideration for the development of a request for devices to be tested. As such, any descriptions of clinical use or test and evaluation studies will be of use. For the purposes of this request for information, we anticipate that devices:

1) Will be able to occlude deep bleeding from aortic and intracavitary hemorrhage, including parenchymal injuries. At a minimum, the device should stop bleeding where a standard tourniquet or junctional tourniquet cannot be applied; 2) Can be applied easily in a tactical environment; 3) Must not slip during tightening or following application; 4) Be capable of easy release and re-application; 5) Be of light weight; 6) Have long shelf life, low cost and low cube.

Bid Protests Not Available